120 related articles for article (PubMed ID: 33400617)
1. Inhibitory effect of resveratrol on the pharmacokinetics of ticagrelor in vivo and in vitro.
Wang P; Hu XX; Li YH; Gao NY; Chen GQ; Chen JL
Can J Physiol Pharmacol; 2021 Aug; 99(8):821-826. PubMed ID: 33400617
[TBL] [Abstract][Full Text] [Related]
2. The effect of resveratrol on pharmacokinetics of aripiprazole in vivo and in vitro.
Zhan YY; Liang BQ; Li XY; Gu EM; Dai DP; Cai JP; Hu GX
Xenobiotica; 2016; 46(5):439-44. PubMed ID: 26391142
[TBL] [Abstract][Full Text] [Related]
3. Effect of Ticagrelor, a Cytochrome P450 3A4 Inhibitor, on the Pharmacokinetics of Tadalafil in Rats.
Na YG; Byeon JJ; Huh HW; Kim MK; Shin YG; Lee HK; Cho CW
Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31330787
[TBL] [Abstract][Full Text] [Related]
4. Effects of resveratrol on P-glycoprotein and cytochrome P450 3A in vitro and on pharmacokinetics of oral saquinavir in rats.
Li J; Liu Y; Zhang J; Yu X; Wang X; Zhao L
Drug Des Devel Ther; 2016; 10():3699-3706. PubMed ID: 27895462
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cytochrome P450 3A4‑mediated drug‑drug interaction potential between P2Y12 inhibitors and statins.
Zhang B; Zhan G; Fang Q; Wang F; Li Y; Zhang Y; Zhao L; Zhang G; Li B
Mol Med Rep; 2019 Nov; 20(5):4713-4722. PubMed ID: 31545497
[TBL] [Abstract][Full Text] [Related]
6. Effects of ticagrelor on the pharmacokinetics of rivaroxaban in rats.
Chong J; Chen H; Dai D; Wang S; Zhou Q; Liu J; Lü Y; Wu H; Du M; Chen F; Jiang H; Zhou Y; Yang J
Pharm Biol; 2020 Dec; 58(1):630-635. PubMed ID: 32633174
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of resveratrol on the pharmacokinetic of ibrutinib by UPLC-MS/MS.
Wen J; Bao SS; Zhang BW; Liu TH; Ou-Yang QG; Cai JP; Zhou HY
Drug Dev Ind Pharm; 2019 Jan; 45(1):27-31. PubMed ID: 30156133
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of potential drug-drug interactions with ticagrelor: cytochrome P450 reaction phenotyping, inhibition, induction, and differential kinetics.
Zhou D; Andersson TB; Grimm SW
Drug Metab Dispos; 2011 Apr; 39(4):703-10. PubMed ID: 21177984
[TBL] [Abstract][Full Text] [Related]
9. Effects of myricetin and quercetin on ticagrelor metabolism and the underlying mechanism.
Wang J; Hu Y; Li Q; Liu YN; Lin J; Xu RA
Chem Biol Interact; 2024 Apr; 392():110924. PubMed ID: 38401715
[TBL] [Abstract][Full Text] [Related]
10. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
11. Effect of Ginkgo Leaf Tablets on the Pharmacokinetics of Amlodipine in Rats.
Wang R; Zhang H; Sun S; Wang Y; Chai Y; Yuan Y
Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):825-833. PubMed ID: 26650374
[TBL] [Abstract][Full Text] [Related]
12. Effect of tea polyphenols on the oral and intravenous pharmacokinetics of ticagrelor in rats and its in vitro metabolism.
Wang ZT; Xue Y; Sun H; Zhang Z; Tang ZJ; Liu SB; Cai WM
J Food Sci; 2020 Apr; 85(4):1285-1291. PubMed ID: 32157685
[TBL] [Abstract][Full Text] [Related]
13. N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs.
Brandes LJ; Queen GM; LaBella FS
Cancer Chemother Pharmacol; 2000; 45(4):298-304. PubMed ID: 10755318
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism.
Kim SB; Yoon IS; Kim KS; Cho SJ; Kim YS; Cho HJ; Chung SJ; Chong S; Kim DD
Planta Med; 2014 May; 80(7):561-7. PubMed ID: 24710899
[TBL] [Abstract][Full Text] [Related]
15. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
16. Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes.
Seaton MJ; Follansbee MH; Bond JA
Carcinogenesis; 1995 Oct; 16(10):2287-93. PubMed ID: 7586124
[TBL] [Abstract][Full Text] [Related]
17. In-vitro metabolism of glycyrrhetinic acid by human and rat liver microsomes and its interactions with six CYP substrates.
Zhao K; Ding M; Cao H; Cao ZX
J Pharm Pharmacol; 2012 Oct; 64(10):1445-51. PubMed ID: 22943175
[TBL] [Abstract][Full Text] [Related]
18. Effects of Voriconazole on the Pharmacokinetics of Vonoprazan in Rats.
Shen J; Wang B; Wang S; Chen F; Meng D; Jiang H; Zhou Y; Geng P; Zhou Q; Liu B
Drug Des Devel Ther; 2020; 14():2199-2206. PubMed ID: 32581516
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and pharmacokinetics characterization of metarrestin in multiple species.
Padilha EC; Shah P; Wang AQ; Singleton MD; Hughes EA; Li D; Rice KA; Konrath KM; Patnaik S; Marugan J; Rudloff U; Xu X
Cancer Chemother Pharmacol; 2020 Apr; 85(4):805-816. PubMed ID: 32185484
[TBL] [Abstract][Full Text] [Related]
20. Effects of dacomitinib on the pharmacokinetics of poziotinib
Ji W; Shen J; Wang B; Chen F; Meng D; Wang S; Dai D; Zhou Y; Wang C; Zhou Q
Pharm Biol; 2021 Dec; 59(1):457-464. PubMed ID: 33899675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
